The Journal of Thoracic and Cardiovascular Surgery
Volume 137, Issue 6 , Pages 1436-1442.e2, June 2009

Impact of preconditioning protocol on anesthetic-induced cardioprotection in patients having coronary artery bypass surgery

  • Jan Fräßdorf, MD

      Affiliations

    • Department of Anesthesiology, Academic Medical Center AMC, University of Amsterdam, Amsterdam, The Netherlands
    • Department of Anesthesiology, University Hospital Duesseldorf, Duesseldorf, Germany
  • ,
  • Andreas Borowski, MD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, University Hospital Duesseldorf, Duesseldorf, Germany
  • ,
  • Dirk Ebel, MD

      Affiliations

    • Department of Anesthesiology, University Hospital Duesseldorf, Duesseldorf, Germany
    • Department of Anesthesiology, Slingeland Ziekenhuis, Doetinchem, The Netherlands
  • ,
  • Peter Feindt, MD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, University Hospital Duesseldorf, Duesseldorf, Germany
  • ,
  • Manuel Hermes, MD

      Affiliations

    • Department of Anesthesiology, University Hospital Duesseldorf, Duesseldorf, Germany
  • ,
  • Thomas Meemann, MD

      Affiliations

    • Department of Anesthesiology, University Hospital Duesseldorf, Duesseldorf, Germany
  • ,
  • René Weber, MD

      Affiliations

    • Department of Anesthesiology, University Hospital Duesseldorf, Duesseldorf, Germany
  • ,
  • Jost Müllenheim, MD, DEAA

      Affiliations

    • Department of Anesthesiology, South Tyneside District Hospital, South Shields, United Kingdom
  • ,
  • Nina C. Weber, PhD

      Affiliations

    • Department of Anesthesiology, Academic Medical Center AMC, University of Amsterdam, Amsterdam, The Netherlands
  • ,
  • Benedikt Preckel, MD, MA, DEAA

      Affiliations

    • Department of Anesthesiology, Academic Medical Center AMC, University of Amsterdam, Amsterdam, The Netherlands
    • Department of Anesthesiology, University Hospital Duesseldorf, Duesseldorf, Germany
    • Corresponding Author InformationAddress for reprints: Benedikt Preckel, MD, MA, DEAA, Academic Medical Center, University of Amsterdam, Postbus 22660 H1Z-120, 1100 DD Amsterdam, The Netherlands.
  • ,
  • Wolfgang Schlack, MD, DEAA

      Affiliations

    • Department of Anesthesiology, Academic Medical Center AMC, University of Amsterdam, Amsterdam, The Netherlands

Received 30 January 2008; accepted 6 April 2008. published online 23 February 2009.

Objective

Anesthetic preconditioning may contribute to the cardioprotective effects of sevoflurane in patients having coronary artery bypass surgery. We investigated whether 2 different sevoflurane administration protocols can induce preconditioning in patients having coronary artery bypass.

Methods

Thirty patients were randomly allocated to 1 of 3 groups. All patients received a total intravenous anesthesia with sufentanil (0.3 μg−1 · kg· h−1) and propofol as target controlled infusion (2.5 μg/mL). The control group had no further intervention; 10 minutes prior to establishing the extracorporeal circulation, patients of the sevoflurane-I group received 1 minimum alveolar concentration of sevoflurane for 5 minutes. Patients of the sevoflurane-II group received (2 times) 5 minutes of sevoflurane, interspersed by 5-minute washout 10 minutes prior to extracorporeal circulation. Troponin I was measured as marker of cardiac cellular damage.

Results

Peak levels of troponin I release were observed at 4 hours after cardiopulmonary bypass and were not affected by 1 cycle of sevoflurane administration (controls: 14 ± 3 ng/mL vs sevoflurane-I group, 14 ± 3 ng/mL). Two periods of sevoflurane preconditioning significantly reduced cellular damage compared with controls (peak troponin I level sevoflurane-II group, 7 ± 2 ng/mL).

Conclusion

These data show that sevoflurane-induced preconditioning is reproducible in patients having coronary artery bypass but depends on the preconditioning protocol used.

Abbreviations and Acronyms: APC, anesthetic-induced pharmacologic preconditioning of the heart, BNP, brain natriuretic peptide, CABG, coronary artery bypass graft, CI, cardiac index, CK, creatine kinase, CPB, cardiopulmonary bypass, CVP, central venous pressure, dP/dtmax, maximum rate of LV pressure increase, EuroSCORE, European System for Cardiac Operative Risk Evaluation, ICU, intensive care unit, IPC, ischemic preconditioning, LV, left ventricular, MAC, minimum alveolar concentration, MAP, mean arterial pressure, PKC, protein kinase C, TnI, troponin I

CTSNet classification: 1, 25, 30, 31

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Part of the work has been presented at the ASA meeting 2005, Atlanta, and at the ASA annual meeting 2004, Las Vegas.

 Support was provided from Deutsche Forschungsgemeinschaft (Bonn, Germany, grant No. SCHL 448/5-1), Siemens Medical Solutions Diagnostics (Fernwald, Germany), Abbott GmbH (Wiesbaden, Germany), and institutional resources.

PII: S0022-5223(08)01740-6

doi:10.1016/j.jtcvs.2008.04.034

The Journal of Thoracic and Cardiovascular Surgery
Volume 137, Issue 6 , Pages 1436-1442.e2, June 2009